论文部分内容阅读
迄今,外科手术仍为小肝癌治疗的主要手段,但术后局部复发和转移是影响其生存率的主要因素。为评价预防性动脉内化疗栓塞(Preventive HAI/HAE)在小肝癌术后的临床价值,作者对单发,直径≤3.0cm,术前CT未发现肝内其它结节,术中B超门脉主干无癌栓的小肝癌患者,于手术后进行预防性动脉内化疗栓塞治疗。并与同期不行任何化疗栓塞的同等大小肝癌患者进行比较,同时比较两组患者切除术后CT和B超随访发现复发和转移的时间。 1 临床资料和方法 1989年1月至1994年12月,上海医科大学中山医院肝癌研究所及福州军区总医院肝胆外科共行小肝
So far, surgery is still the main method for the treatment of small hepatocellular carcinoma, but local recurrence and metastasis are the main factors affecting the survival rate. To evaluate the clinical value of Preventive Arterial Chemoembolization (Preventive HAI/HAE) in the treatment of small hepatocellular carcinoma, the authors of a single, diameter ≤3.0cm, no other intrahepatic nodules were found before surgery, intraoperative B ultrasound portal vein Patients with small hepatocellular carcinoma who had no cancer thrombus in the trunk were treated with prophylactic intraarterial chemoembolization after surgery. Compared with patients with hepatocellular carcinoma of the same size who did not undergo any chemoembolization during the same period, the time of recurrence and metastasis after CT and B-ultrasonography were compared between the two groups. 1 Clinical data and methods From January 1989 to December 1994, the Liver and Gallbladder Surgery Department of the Hepatobiliary Institute of Zhongshan Hospital of Shanghai Medical University and the General Hospital of Fuzhou Military Command performed a small liver operation.